FluCure
In this collaborative project Beactica is, together with a number of partners, aiming to discover new classes of antiviral drugs against influenza .
SynSys
Beactica participates in this European expertise network that aims at molecular analysis and dynamic modeling of synapse function. The perspective is to generate a blueprint for the discovery of novel pathways and targets that enable rational strategies to design therapies for human brain disease.
BrainTrain
Beactica participates in this initial training network, ITN, that builds on our knowledge of genome information and that aims to develop a new generation of neuroscientists, contributing to the fight against brain disorders.
NeuroCypres
Beactica’s role in this collaborative large-scale integrating project is to discover new classes of drugs targetting Cys-loop receptors, a superfamily of ligand-gated ion channels.
